''Drug and medical device company Covidien said Nov. 9 that it is changing the label of its imaging agent Optimark to indicate that it is dangerous for use in patients with severe renal impairment. Optimark gadoversetamide injection is a ...'
Wednesday, 11 November 2009 by www.renalbusiness.com